Skip to content
value.today

Paradigm Diagnostics, Inc.

🇺🇸 Phoenix, Arizona, USAPharmaceuticalsFounded 2016

Formerly Paradigm Diagnostics, LLC, Paradigm Diagnostics

Total raised
$11 M
1 round on record
Latest round
$11 M
Nov 2016
First round on record
Nov 2016
Today
Private
No later event on record

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Paradigm Diagnostics, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Nov 2016$11 MNo. 1$10 to $50 million

Paradigm Diagnostics, Inc.: Raise no. 1, Nov 2016

Investors in this round

12 investors had bought by the notice of Dec 4, 2018: 12 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$11 M of $13 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David Mallery · Executive Officer, Director
  • David Neal · Executive Officer
  • Scott Morris · Executive Officer
  • Carey Ng · Director
  • Erin Curley · Director
  • Grace Colon · Director
  • Robert Armknecht · Director
  • Rodney Markin · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by David Mallery, President and CEO. Source: SEC Form D and 3 amendments, newest notice filed Dec 4, 2018. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Paradigm Diagnostics, Inc. chose not to state its revenue in its newest notice of a funding round (Dec 2018).

    SEC Form D · Dec 2018

  • The industry group it chose in its notices: Pharmaceuticals.

    SEC Form D · Dec 2018

That is all the official record says: Paradigm Diagnostics, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Paradigm Diagnostics, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 12 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Paradigm Diagnostics, Inc.
NameRoleNamed in
David MalleryExecutive officerDec 2018
David NealExecutive officerDec 2018
Scott MorrisExecutive officerDec 2018
Carey NgDirectorDec 2018
David MalleryDirectorDec 2018
Erin CurleyDirectorDec 2018
Grace ColonDirectorDec 2018
Robert ArmknechtDirectorDec 2018
Rodney MarkinDirectorDec 2018